# OnCo record paper-cancerguard-mp-classifier-cebp-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-cancerguard-mp-classifier-cebp-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-cancerguard-mp-classifier-cebp-2026" ;
  schema:name "Performance of a multi-biomarker class, multi-cancer early detection (MCED) blood test in a prospectively collected cohort"@en ;
  schema:description "Exact Sciences' development study of the methylation and protein classifier behind Cancerguard: it found about half of cancers overall but about one in seven stage I cancers."@en ;
  schema:url <https://onco.cc/key-papers/paper-cancerguard-mp-classifier-cebp-2026/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/1055-9965.EPI-26-0541>, <https://pubmed.ncbi.nlm.nih.gov/42826075/> ;
  schema:sameAs <https://doi.org/10.1158/1055-9965.EPI-26-0541> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Gainullin VG, Manesse M, Zhuang F, et al." ;
  onco:sections <https://onco.cc/fronts/early-detection/> ;
  onco:technologies <https://onco.cc/technologies/mced/>, <https://onco.cc/technologies/cfdna-methylation-testing/>, <https://onco.cc/technologies/proteomics/> ;
  onco:drugs <https://onco.cc/drugs/cancerguard/> ;
  onco:companies <https://onco.cc/companies/exact-sciences/> ;
  onco:journals <https://onco.cc/journals/cancer-epidemiology-biomarkers-prevention/> .